Overview

Study to Evaluate the Effect of Different Warm-Up Times of Risankizumab Autoinjector (AI) on the Injection Pain Experiences in Healthy Volunteers

Status:
Completed
Trial end date:
2021-04-07
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the impact of different warm-up times of risankizumab autoinjector (AI) on the participant injection site pain experience in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
AbbVie